This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carrasco, C. A. Articles by Fardella, C. E. Search for Related Content PubMed PubMed Citation Articles by Carrasco, C. A. Articles by Fardella, C. E. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB GUANINE

Novel Intronic Mutation of MEN1 Gene Causing Familial Isolated Primary Hyperparathyroidism

Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; and Department of Endocrinology, Faculty of Medicine, Universidad de Chile, Santiago, Chile

Address all correspondence and requests for reprints to: Carlos E. Fardella, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Lira 85, piso 5, Santiago, Chile. E-mail: cfardella{at}med.puc.cl.

Primary hyperparathyroidism may occur as part of hereditary syndromes, including multiple endocrine neoplasia types 1 and 2A (MEN1 and MEN2A), hyperparathyroidism-jaw tumor syndrome, and the familial isolated hyperparathyroidism (FIHP). It is unclear whether FIHP corresponds to a different genetic entity or a variant of MEN1 (or hyperparathyroidism-jaw tumor syndrome). We report a patient and 11 family members with FIHP in whom we identified a heterozygous G-to-A mutation at nucleotide 7361 of tumor suppressor MEN1 gene. This mutation is located in the first base of intron 9 (IVS9 + 1 G>A). All the family members with hyperparathyroidism were heterozygous for the intronic mutation. In vitro studies were performed in COS cells transfected with minigenes carrying the coding regions spanning exon-intron 9 and 10 with the mutant and the wild-type sequences. RT-PCR analyses showed an abnormal mRNA of greater size (829 bp) in the mutated MEN1 gene than the normal transcript (629 bp). The longer PCR product includes the exon 9, the unspliced intron 9, and part of exon 10. RT-PCR of MEN1 mRNA from patient’s blood confirmed the existence of unspliced intron 9 in mature mRNA. In summary, we report a case of FIHP associated with a new intronic heterozygous germline mutation (IVS9 + 1 G>A) of MEN1 gene. This mutation produces an aberrant splicing of mRNA that could lead to a truncated protein, without activity, explaining the clinical picture of this patient and his family.

This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile 1011035-19801351040834 and Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile.

Abbreviations: CT, Computed tomography; FIHP, familial isolated HPT; HC, healthy control; HPT, hyperparathyroidism; HPT-JT, HPT-jaw tumor; MEN, multiple endocrine neoplasia; NLS, nuclear localization signal; OMIM, Online Mendelian Inheritance in Man.

This article has been cited by other articles:

				M. C Lemos, B. Harding, A. A C Reed, J. Jeyabalan, G. V Walls, M. R Bowl, J. Sharpe, S. Wedden, J. E Moss, A. Ross, et al. Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers J. Endocrinol., October 1, 2009; 203(1): 133 - 142. [Abstract] [Full Text] [PDF]

				A. Beckers and A. F Daly The clinical, pathological, and genetic features of familial isolated pituitary adenomas Eur. J. Endocrinol., October 1, 2007; 157(4): 371 - 382. [Abstract] [Full Text] [PDF]

				V. M. Howell, J. W. Cardinal, A.-L. Richardson, O. Gimm, B. G. Robinson, and D. J. Marsh Rapid Mutation Screening for HRPT2 and MEN1 Mutations Associated with Familial and Sporadic Primary Hyperparathyroidism J. Mol. Diagn., November 1, 2006; 8(5): 559 - 566. [Abstract] [Full Text] [PDF]

				S. J. Marx and W. F. Simonds Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes Endocr. Rev., August 1, 2005; 26(5): 615 - 661. [Abstract] [Full Text] [PDF]

				K. Frank-Raue, S. Rondot, W. Hoeppner, P. Goretzki, F. Raue, and W. Meng Coincidence of Multiple Endocrine Neoplasia Types 1 and 2: Mutations in the RET Protooncogene and MEN1 Tumor Suppressor Gene in a Family Presenting with Recurrent Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4063 - 4067. [Abstract] [Full Text] [PDF]